Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immuno-oncology (378) 378
science & technology (287) 287
life sciences & biomedicine (278) 278
oncology (193) 193
immunotherapy (178) 178
humans (116) 116
cancer (115) 115
tumors (64) 64
immunology (60) 60
pharmacology & pharmacy (52) 52
clinical trials (46) 46
immuno‐oncology (44) 44
review (43) 43
cancer therapies (42) 42
melanoma (42) 42
biomarkers (40) 40
neoplasms - immunology (40) 40
metastasis (38) 38
immunotherapy - methods (37) 37
animals (36) 36
patients (36) 36
chemotherapy (34) 34
antigens (33) 33
lung cancer (33) 33
immune system (32) 32
lymphocytes (30) 30
immune checkpoint (29) 29
neoplasms. tumors. oncology. including cancer and carcinogens (29) 29
cancer immunotherapy (28) 28
care and treatment (28) 28
research (28) 28
immune response (27) 27
pd-1 (27) 27
pd-l1 (27) 27
t cells (27) 27
tumor microenvironment (25) 25
analysis (24) 24
apoptosis (24) 24
cytotoxicity (24) 24
female (24) 24
lymphocytes t (24) 24
neoplasms - therapy (24) 24
gene expression (23) 23
metastases (23) 23
medicine, research & experimental (22) 22
research & experimental medicine (22) 22
medical research (21) 21
medicine & public health (20) 20
biomarker (19) 19
precision medicine (19) 19
proteins (19) 19
checkpoint inhibitors (18) 18
health aspects (18) 18
male (18) 18
medical prognosis (18) 18
mutation (18) 18
neoplasms - drug therapy (18) 18
cell death (17) 17
immune checkpoint inhibitors (17) 17
medicine (17) 17
middle aged (17) 17
pd-l1 protein (17) 17
prognosis (17) 17
treatment outcome (17) 17
usage (17) 17
kinases (16) 16
pembrolizumab (16) 16
aged (15) 15
hematology (15) 15
immune checkpoint inhibitor (15) 15
immunohistochemistry (15) 15
mice (15) 15
nivolumab (15) 15
antineoplastic agents - therapeutic use (14) 14
cancer research (14) 14
genetic aspects (14) 14
original research (14) 14
physical sciences (14) 14
adult (13) 13
biochemistry & molecular biology (13) 13
breast cancer (13) 13
fda approval (13) 13
neoplasms - pathology (13) 13
nsclc (13) 13
pharmacology (13) 13
survival analysis (13) 13
antibodies (12) 12
antibodies, monoclonal - therapeutic use (12) 12
drug development (12) 12
genomics (12) 12
inflammation (12) 12
monoclonal antibodies (12) 12
programmed cell death 1 receptor - antagonists & inhibitors (12) 12
radiation therapy (12) 12
antineoplastic agents, immunological - therapeutic use (11) 11
chemistry, medicinal (11) 11
ctla-4 (11) 11
drug therapy (11) 11
innate immunity (11) 11
ipilimumab (11) 11
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (441) 441
Chinese (5) 5
French (5) 5
German (5) 5
Japanese (2) 2
Russian (2) 2
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Immune Landscape of Cancer
by Thorsson, Vésteinn and Brown, Scott D and Wolf, Denise and Bortone, Dante S and Ou Yang, Tai-Hsien and Malhotra, Raunaq and Farshidfar, Farshad and Parker, Joel S and Mose, Lisle E and Liu, Jianfang and Liu, Yuexin and Bowlby, Reanne and Califano, Andrea and Cherniack, Andrew D and Anastassiou, Dimitris and Bedognetti, Davide and Rao, Arvind and Krasnitz, Alexander and Hu, Hai and Malta, Tathiane M and Noushmehr, Houtan and Pedamallu, Chandra Sekhar and Bullman, Susan and Zhou, Wanding and Shen, Hui and Holt, Robert A and Rabkin, Charles S and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Hutter, Carolyn M and Sofia, Heidi J and Wang, Zhining and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Chudamani, Sudha and Liu, Jia and Wu, Ye and Cho, Juok and Frazer, Scott and Getz, Gad and Lawrence, Michael S and Meier, Sam and Noble, Michael S and Chambwe, Nyasha and Knijnenburg, Theo and Leinonen, Kalle and Miller, Michael and Reynolds, Sheila and Shmulevich, Ilya and Akbani, Rehan and Hegde, Apurva M and Kanchi, Rupa S and Korkut, Anil and Liang, Han and Liu, Wenbin and Lu, Yiling and Ng, Kwok-Shing and Rao, Arvind and Ryan, Michael and Zhang, Jiexin and Abeshouse, Adam and Chakravarty, Debyani and Chatila, Walid K and de Bruijn, Ino and Gao, Jianjiong and Kundra, Ritika and Luna, Augustin and Nissan, Moriah G and Ochoa, Angelica and Reznik, Ed and Sanchez-Vega, Francisco and Schultz, Nikolaus and Sheridan, Robert and Sumer, S. Onur and Sun, Yichao and Anur, Pavana and Benz, Christopher and Stuart, Joshua M and Wong, Christopher K and Yau, Christina and Hayes, D. Neil and Parker, Joel S and Wilkerson, Matthew D and Ally, Adrian and Balasundaram, Miruna and Bowlby, Reanne and Carlsen, Rebecca and Chuah, Eric and Dhalla, Noreen and Holt, Robert and Jones, Steven J.M and Lee, Darlene and Marra, Marco A and Mayo, Michael and Moore, Richard A and Mungall, Karen and Schein, Jacqueline E and Sipahimalani, Payal and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network
Immunity (Cambridge, Mass.), ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 812 - 830.e14
tumor immunology | immunotherapy | cancer genomics | integrative network analysis | immuno-oncology | tumor microenvironment | immune subtypes | immunomodulatory | Immunology | Infectious Diseases | Immunology and Allergy | Life Sciences & Biomedicine | Science & Technology | Cell proliferation | Cluster analysis | Transcription | Copy number | p53 Protein | Lung cancer | Genomics | Aneuploidy | Lymphocytes T | Genomes | Cell interactions | Macrophages | Immunotherapy | DNA methylation | miRNA | Deoxyribonucleic acid--DNA | Immune system | Medical research | Wound healing | Immunomodulation | Stockholders | Inflammation | T cell receptors | Communications networks | Gene expression | White blood cells | Inventors | Medical prognosis | γ-Interferon | Mutation | Cancer | Tumors | Index Medicus | Immune Subtypes | Integrative Network Analysis | Cancer Genomics | Immuno-oncology | Tumor immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
by Yue, Eddy W and Sparks, Richard and Polam, Padmaja and Modi, Dilip and Douty, Brent and Wayland, Brian and Glass, Brian and Takvorian, Amy and Glenn, Joseph and Zhu, Wenyu and Bower, Michael and Liu, Xiangdong and Leffet, Lynn and Wang, Qian and Bowman, Kevin J and Hansbury, Michael J and Wei, Min and Li, Yanlong and Wynn, Richard and Burn, Timothy C and Koblish, Holly K and Fridman, Jordan S and Emm, Tom and Scherle, Peggy A and Metcalf, Brian and Combs, Andrew P
ACS medicinal chemistry letters, ISSN 1948-5875, 05/2017, Volume 8, Issue 5, pp. 486 - 491
Epacadostat | data-centric medicinal chemistry | immuno-oncology | INCB24360 | IDO1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
by Saltz, Joel and Gupta, Rajarsi and Kurc, Tahsin and Singh, Pankaj and Nguyen, Vu and Shroyer, Kenneth R and Zhao, Tianhao and Batiste, Rebecca and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Hutter, Carolyn M and Sofia, Heidi J and Tarnuzzer, Roy and Yang, Liming and Zenklusen, Jean C and Chudamani, Sudha and Naresh, Rashi and Pihl, Todd and Sun, Qiang and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Heiman, David I and Lawrence, Michael S and Lin, Pei and Meier, Sam and Noble, Michael S and Saksena, Gordon and Voet, Doug and Zhang, Hailei and Bernard, Brady and Chambwe, Nyasha and Dhankani, Varsha and Knijnenburg, Theo and Kramer, Roger and Leinonen, Kalle and Miller, Michael and Shmulevich, Ilya and Thorsson, Vesteinn and Zhang, Wei and Hegde, Apurva M and Ju, Zhenlin and Korkut, Anil and Li, Jun and Liang, Han and Ling, Shiyun and Liu, Wenbin and Lu, Yiling and Mills, Gordon B and Ng, Kwok-Shing and Abeshouse, Adam and Chakravarty, Debyani and Chatila, Walid K and de Bruijn, Ino and Gao, Jianjiong and Heins, Zachary J and Kundra, Ritika and Ladanyi, Marc and Luna, Augustin and Ochoa, Angelica and Phillips, Sarah M and Sanchez-Vega, Francisco and Sander, Chris and Schultz, Nikolaus and Sumer, S. Onur and Taylor, Barry S and Wang, Jioajiao and Zhang, Hongxin and Anur, Pavana and Peto, Myron and Spellman, Paul and Benz, Christopher and Stuart, Joshua M and Wong, Christopher K and Yau, Christina and Hayes, D. Neil and Wilkerson, Matthew D and Ally, Adrian and Brooks, Denise and Carlsen, Rebecca and Dhalla, Noreen and Holt, Robert and Jones, Steven J.M and Kasaian, Katayoon and Lee, Darlene and Ma, Yussanne and Marra, Marco A and Mayo, Michael and Mungall, Andrew J and Robertson, A. Gordon and Schein, Jacqueline E and Sipahimalani, Payal and Tse, Kane and Wong, Tina and Berger, Ashton C and Beroukhim, Rameen and Gabriel, Stacey B and Meyerson, Matthew and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Cell reports (Cambridge), ISSN 2211-1247, 04/2018, Volume 23, Issue 1, pp. 181 - 193.e7
deep learning | lymphocytes | digital pathology | bioinformatics | computer vision | tumor-infiltrating lymphocytes | immuno-oncology | tumor microenvironment | machine learning | artificial intelligence | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Lymphocytes, Tumor-Infiltrating - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Neoplasms - pathology | Humans | Image Interpretation, Computer-Assisted - methods | Deep Learning | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
by Cheong, Jae Eun and Sun, Lijun
Trends in pharmacological sciences (Regular ed.), ISSN 0165-6147, 03/2018, Volume 39, Issue 3, pp. 307 - 325
KYN | AhR | immuno-oncology | TDO2 | KYNase | IDO1 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
by Tonneau, Marion and Elkrief, Arielle and Pasquier, David and Paz Del Socorro, Thomas and Chamaillard, Mathias and Bahig, Houda and Routy, Bertrand
Radiotherapy and oncology, ISSN 0167-8140, 03/2021, Volume 156, pp. 1 - 9
Mucositis | Radiation therapy | Vancomycin | Gut microbiome | Immuno-oncology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab
by Scott, Susan C and Pennell, Nathan A
Journal of thoracic oncology, ISSN 1556-0864, 11/2018, Volume 13, Issue 11, pp. 1771 - 1775
immuno-oncology | NSCLC | nivolumab | corticosteroids | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Peptides that immunoactivate the tumor microenvironment
by Furukawa, Natsuki and Popel, Aleksander S
Biochimica et biophysica acta. Reviews on cancer, ISSN 0304-419X, 01/2021, Volume 1875, Issue 1, pp. 188486 - 188486
Therapeutic peptides | Tumor microenvironment | Immunomodulation | Immuno-oncology | Immunotherapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Comprehensive analysis of the clinical immuno-oncology landscape
by Tang, J and Shalabi, A and Hubbard-Lucey, V M
Annals of oncology, ISSN 0923-7534, 01/2018, Volume 29, Issue 1, pp. 84 - 91
Landscape analysis | Clinical trials | Cancer immunotherapy | Immuno-oncology | Tumor immunology | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - therapy | Clinical Trials as Topic | Antineoplastic Agents, Immunological - therapeutic use | Neoplasms - immunology | Humans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In vivo imaging of the programmed death ligand 1 by18F PET
by González Trotter, Dinko E and Meng, Xiangjun and McQuade, Paul and Rubins, Daniel and Klimas, Michael and Zeng, Zhizhen and Connolly, Brett M and Miller, Patricia J and O’Malley, Stacey S and Lin, Shu-An and Getty, Krista L and Fayadat-Dilman, Laurence and Liang, Linda and Wahlberg, Elisabet and Widmark, Olof and Ekblad, Caroline and Frejd, Fredrik Y and Hostetler, Eric D and Evelhoch, Jeffrey L
Journal of Nuclear Medicine, ISSN 0161-5505, 11/2017, Volume 58, Issue 11, pp. 1852 - 1857
Programmed death ligand 1 | 18F-AlF-NOTA-ZPD-L1_1 | Immuno-oncology | Positron emission tomography
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights